Kestra Medical Technologies (KMTS) Income towards Parent Company (2024 - 2026)

Kestra Medical Technologies (KMTS) has reported Income towards Parent Company for 3 consecutive years, with $77.3 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Income towards Parent Company rose 267.07% year-over-year to $77.3 million; the TTM figure through Apr 2026 stood at -$15.5 million (up 85.81% YoY), while the FY2026 annual figure was -$15.5 million, up 85.81% from the prior year.
• Income towards Parent Company climbed to $77.3 million in Q2 2026 per KMTS's latest filing, from -$34.2 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at $77.3 million in Q2 2026 and bottomed at -$46.3 million in Q2 2025.
• Historically, Income towards Parent Company has averaged -$16.6 million across 3 years, with a median of -$21.7 million in 2024.
• Annual changes were most pronounced in 2025 — Income towards Parent Company sank 132.13% — and 2026, when it surged 267.07%.
• Kestra Medical Technologies' Income towards Parent Company stood at -$20.6 million in 2024, then plunged by 58.99% to -$32.8 million in 2025, then soared by 335.82% to $77.3 million in 2026.
• Business Quant data shows KMTS's Income towards Parent Company at $77.3 million in Q2 2026, -$34.2 million in Q1 2026, and -$32.8 million in Q4 2025.